Filing Details
ADIAL PHARMACEUTICALS, INC. (NASDAQ:ADIL) filed a Form 8-K with the Securities and Exchange Commission on August 17, 2026, disclosing a material event.
8k filedNASDAQ:ADIL
ADIAL PHARMACEUTICALS, INC. (ADIL) Reports Material Event to SEC
ADIAL PHARMACEUTICALS, INC. (NASDAQ:ADIL) filed a Form 8-K with the Securities and Exchange Commission on August 17, 2026, disclosing a material event.
At publication ·
What changed
ADIAL PHARMACEUTICALS, INC. (NASDAQ:ADIL) · 8k filed
- Form
- 8-K
At a glance
Key takeaways
- ADIAL PHARMACEUTICALS, INC. (NASDAQ:ADIL) filed a Form 8-K with the SEC on August 17, 2026, disclosing a material event that shareholders should be aware of.
- The stock trades at $4.99 with a market capitalization of $2.4 million.
- The article does not specify the nature of the material event, which could involve leadership changes, material agreements, acquisitions, asset sales, or changes to financial guidance.
Market Context
ADIAL PHARMACEUTICALS, INC.'s stock currently trades at $4.99 with a market capitalization of $2.4M. The Healthcare company's stock moved following the disclosure.
8-K filings report material events that shareholders should know about between regular quarterly or annual reports. These can include leadership changes, material agreements, acquisitions, asset sales, or changes to financial guidance. The specific nature of the event determines its significance for ADIAL PHARMACEUTICALS, INC.'s stock.
All SEC filings for ADIAL PHARMACEUTICALS, INC. are publicly available through the SEC's EDGAR database. Investors can set up alerts for new filings to stay current on material developments.
Related Tools: View ADIL Stock Page
Frequently Asked Questions
Where can I read ADIL's SEC filings?
Browse all filings on our ADIL SEC filings page.
What types of SEC filings does ADIAL PHARMACEUTICALS, INC. file?
Public companies like ADIAL PHARMACEUTICALS, INC. file annual reports (10-K), quarterly reports (10-Q), material events (8-K), and insider transactions (Form 4) with the SEC.